Triamcinolone acetonide helps to visualize the vitreous during congenital cataract surgery

This study's authors describe their technique of using intracameral triamcinolone acetonide to manage anterior vitreous face disturbance during manual posterior continuous curvilinear capsulorhexis (PCCC) in pediatric patients. They have performed this procedure in 30 eyes of 23 children who have undergone congenital cataract surgery.

The technique can be used after a manual PCCC with or without IOL implantation. Following PCCC completion, the authors inject 0.1 mL of a suspension of preservative-free triamcinolone acetonide (Aurocort) into the PCCC margin and inside of the anterior chamber to visualize the anterior vitreous face and any vitreous in the anterior chamber. Anterior vitrectomy is then performed.

Following IOL implantation in the capsular bag in relevant cases, an additional 0.1 mL of preservative-free triamcinolone acetonide is injected into the anterior chamber to visualize residual vitreous strands. A second anterior vitrectomy is performed if vitreous strands are found. Afterward, triamcinolone is rinsed with balanced salt solution, incisions are sutured with 10.0 nylon and 0.1 mL of moxifloxacin 0.5% is injected into the anterior chamber.

The authors recommend prospective long-term follow-up studies to establish the safety and efficacy of intracameral triamcinolone acetonide.